HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

Vitestro Secures $22 Million (€20...

April 30, 2024

Co-led by return investor Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will support Vitestro’s commercialization in Europe and its organizational expansion into the U.S. market.

E Tech Group Secures New...

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

April 30, 2024

URO-1 Achieves Multiple Milestones Toward Commercializing Its Breakthrough Products for Prostate Biopsy & Other Procedures

URO-1, established in 2017, is an emerging portfolio company of the North Carolina Biotechnology Center which in 2018 provided a $250,000 loan to support the company's early product development.

January 4, 2022

Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing

expedited its development after the company closed Series B financing in September 2021. It recently acquired Ann Arbor Pharmacometrics Group

December 30, 2021

MilliporeSigma Announces $136.7 Mil U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin

With this critical investment, we are expanding much-needed access to essential diagnostic testing as a trusted partner to the world's most sophisticated diagnostic manufacturers," said Jean-Charles Wirth, head of Applied Solutions, Life Science.

December 30, 2021

Harris Williams Advises TTG Imaging Solutions, LLC on its Sale to Sentinel Capital Partners

“Management and Chief Capital have done a tremendous job establishing TTG as a truly unique platform providing superior service levels for clients and positioning the business for strong growth for many years to come,” said Andy Dixon, a managing director at Harris Williams. “We look forward to seeing the company’s continued success and expansion in partnership with Sentinel.”

December 28, 2021

Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Round

The round, which brings a total of over $8 million in dilutive and non-dilutive financing to date, includes participation from Creative Ventures, Portal Innovations, Lateral Capital, Cedars-Sinai Accelerator, Kyto Life Science and Technology, Band of Angels, Northwestern University's NXT Fund, University of Michigan Social Venture Fund, and private investors.

December 24, 2021

Filterlex Medical, Selected to Receive €7M from the European Innovation Council

Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of Filterlex's next round of financing. This combined funding will go towards clinical program expansion, regulatory approvals, and commercialization of the CAPTIS® full-body embolic protection system to help transform left-heart procedures. Following a rigorous screening process under Horizon 2020, Filterlex's innovative technology was selected as one of only 99 winning companies...

December 21, 2021

ViCentra Closes EUR 65M (USD 74M) Series C Funding

Proceeds will be used for commercial European launch of updated Kaleido insulin patch pump system including automated insulin delivery (AID) or closed loop

December 16, 2021

Conavi Medical Enters into Funding Agreements for Over $20 Million

“This transformational funding is a testament to the potential the Novasight Hybrid System has on a global scale. It provides the Company with the runway to reach important operational and commercial milestones as we drive the value proposition of this innovative system,” said Thomas Looby, chief executive officer, Conavi Medical.

December 15, 2021

Sirius Medical Announces Second Closing of A-Round Financing

Financing enables the company to execute and accelerate growth plans as well as further develop the company's innovation pipeline to deliver superior navigation technology to physicians and patients worldwide.

December 14, 2021